AmerisourceBergen Corporation company logo

# RNN 1st Gen Model AmerisourceBergen Corporation Drugs, proprietaries, & sundries

Prediction models:
78.57% successful of 42 deals
$ 98.42 Last close price
at 23-feb-2018


Model's trade recommendations 10.63% Return for period

-6.04% Annual return

$21.65B Market Cap

β 1.02  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 10.63%
52wk return -1.60%
52wk Range
Sortino ratio -0.34
Sharpe ratio -0.30
Norm. RMSE 1.00%
Downside risk 14.79%
Volatility 17.03%
  • 1.52 (1.54%) Div (Yield)
  • BUY Analysts consensus recommendation

AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for AmerisourceBergen Corporation (ABC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for ABC model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 160M
P/E 16.21
Shares Outstanding 220M
% Held by Insiders 27.30%
% Held by Institutions 65.98%
EPS (last reported FY) $5.88
EPS (last reported Q) $1.55
EPS, estimated (last reported Q) $1.35
Total revenues $153 B
Net income $0 B